Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

IVUS vs OCT to Guide PCI: Which Should We Choose?

Controlling stent expansion with optical coherence tomography (OCT) based on an external elastic membrane–based protocol for stent sizing resulted non-inferior to the control group which used intravascular ultrasound (IVUS) and superior the angiography only group. Based on these study outcomes and the prior outcomes, we should use IVUS imaging if available. 

IVUS vs OCT para guiar la angioplastia ¿Cuál elegir?

There are no specific algorithms to guided PCI with OCT and neither is there much information on its relative benefits vs. IVUS.

The iSIGHT trial carried out by our Brazilian colleagues, recently published in Circulation Cardiovascular Interventions, has provided significant data on the matter, which makes us proud. 

All patients receiving PCI in at least one native lesion in coronary arteries between 2.25 and 4 mm in diameter, were randomized 1:1:1 to OCT, IVUS or angiography alone. 

An external elastic membrane–based protocol was applied for stent sizing in patients guided by IVUS and OCT.

The primary end point was non-inferiority of OCT vs IVUS to reach optimal stent expansion (minimum stent area ≥90% of the average reference lumen area)


Read also: Cerebral Protection Devices during TAVR in the Daily Practice.


It included 156 lesions (151 patients), 51 receiving OCT, 52 IVUS and 53 angiography.

Stent expansion with OCT (98.01 ± 16.14%) resulted non-inferior to the one obtained with IVUS (91.69 ± 15.75%) and superior to the angiography one (90.53 ± 14.84%, p=0.041).

Stent expansion obtained with IVUS was not superior to the one obtained with angiography alone (p=0.921). This should not discourage the use of IVUS, supported by significant evidence. 

Conclusion

Stent expansion with OCT based on an external elastic membrane–based protocol for stent sizing resulted non-inferior to the one obtained with IVUS and superior to the one obtained with angiography.

Original Title: Optical Coherence Tomography Versus Intravascular Ultrasound and Angiography to Guide Percutaneous Coronary Interventions. The iSIGHT Randomized Trial.

Reference: Daniel Chamié et al. Circulation: Cardiovascular Interventions. 2021;14:e009452. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009452.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...